Inhibitory Effects of Two Major Isoflavonoids in Radix Astragali on High Glucose-Induced Mesangial Cells Proliferation and AGEs-Induced Endothelial Cells Apoptosis

Abstract

Radix Astragali, the dried roots of Astragalus membranaceus var. mongholicus, is well known to have a protective effect on diabetic nephropathy. However, the effects of isoflavonoids in Radix Astragali on glomerular cells, which play a key role in the development of diabetic vascular complications, remain largely unknown. Thus, the purpose of this study was to investigate in vitro the effect of calycosin and calycosin-7-O-β-D-glucoside, two major isoflavonoids in Radix Astragali, on high glucose-induced rat mesangial cells proliferation and AGEs-induced human glomerular endothelial cell apoptosis. The results indicated that both calycosin and calycosin-7-O-β-D-glucoside (10–100 µM) could inhibit high glucose-induced mesangial cell early proliferation. Additionally, AGEs-mediated cell apoptosis was also attenuated by treatment of glomerular endothelial cells with either calycosin or calycosin-7-O-β-D-glucoside (1–100 µM). Therefore, the results obtained in this study suggest that both calycosin and calycosin-7-O-β-D-glucoside have a significant therapeutic potential to modulate the development and/or progression of diabetic nephropathy.

Radix Astragali - calycosin - calycosin-7-O-β-D-glucoside - mesangial cells - proliferation - glomerular endothelial cells

References

• 1 Giunti S, Barit D, Cooper M E. Diabetic nephropathy: from mechanisms to rational therapies.  Minerva Med. 2006;  97 241-262
• 2 Danesh F R, Sadeghi M M, Amro N, Philips C, Zeng L, Lin S, Sahai A, Kanwar Y S. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p 21 signaling pathway: implications for diabetic nephropathy.  Proc Natl Acad Sci USA. 2002;  99 8301-8305
• 3 Jeong S I, Kim K J, Choi M K, Keum K S, Lee S, Ahn S H, Back S H, Song J H, Ju Y S, Choi B K, Jung K Y. alpha-Spinasterol isolated from the root of Phytolacca americana and its pharmacological property on diabetic nephropathy.  Planta Med. 2004;  70 736-739
• 4 Sheetz M J, King G L. Molecular understanding of hyperglycemia's adverse effects for diabetic complications.  J Am Med Assoc. 2002;  288 2579-2588
• 5 Isermann B, Vinnikov I A, Madhusudhan T, Herzog S, Kashif M, Blautzik J, Corat M A, Zeier M, Blessing E, Oh J, Gerlitz B, Berg D T, Grinnell B W, Chavakis T, Esmon C T, Weiler H, Bierhaus A, Nawroth P P. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.  Nat Med. 2007;  13 1349-1358
• 6 Rojas A, Morales M A. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes.  Life Sci. 2004;  76 715-730
• 7 Xiang M, Yang M, Zhou C, Liu J, Li W, Qian Z. Crocetin prevents AGEs-induced vascular endothelial cell apoptosis.  Pharmacol Res. 2006;  54 268-274
• 8 Zhang J, Xie X, Li C, Fu P. Systematic review of the renal protective effect of Astragalus membranaceus (root) on diabetic nephropathy in animal models.  J Ethnopharmacol. 2009;  126 189-196
• 9 Song Y, Li P, Wang D, Cheng Y Y. Micellar electrokinetic chromatography for the quantitative analysis of flavonoids in the radix of Astragalus membranaceus var. mongholicus.  Planta Med. 2008;  74 84-89
• 10 Zhang W D, Chen H, Zhang C, Liu R H, Li H L, Chen H Z. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro.  Planta Med. 2006;  72 4-8
• 11 Mao X Q, Yu F, Wang N, Wu Y, Zou F, Wu K, Liu M, Ouyang J P. Hypoglycemic effect of polysaccharide enriched extract of Astragalus membranaceus in diet induced insulin resistant C57BL/6J mice and its potential mechanism.  Phytomedicine. 2009;  16 416-425
• 12 Zhang W D, Zhang C, Wang X H, Gao P J, Zhu D L, Chen H, Liu R H, Li H L. Astragaloside IV dilates aortic vessels from normal and spontaneously hypertensive rats through endothelium-dependent and endothelium-independent ways.  Planta Med. 2006;  72 621-626
• 13 Zhu H, Zhang Y, Ye G, Li Z, Zhou P, Huang C. In vivo and in vitro antiviral activities of calycosin-7-O-beta-D-glucopyranoside against coxsackie virus B3.  Biol Pharm Bull. 2009;  32 68-73
• 14 Ryu M, Kim E H, Chun M, Kang S, Shim B, Yu Y B, Jeong G, Lee J S. Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with attenuation of p 38 and Erk.  J Ethnopharmacol. 2008;  115 184-193
• 15 Auyeung K K, Cho C H, Ko J K. A novel anticancer effect of Astragalus saponins: Transcriptional activation of NSAID-activated gene.  Int J Cancer. 2009;  125 1082-1091
• 16 Yuan W, Zhang Y, Ge Y, Yan M, Kuang R, Zheng X. Astragaloside IV inhibits proliferation and promotes apoptosis in rat vascular smooth muscle cells under high glucose concentration in vitro.  Planta Med. 2008;  74 1259-1264
• 17 Nobre Júnior H V, Cunha G M, Moraes M O, Luciana M F, Oliveira R A, Maia F D, Nogueira M A, Lemos T L, Rao V S. Quebrachitol (2-O-methyl-l-inositol) attenuates 6-hydroxydopamine-induced cytotoxicity in rat fetal mesencephalic cell cultures.  Food Chem Toxicol. 2006;  44 1544-1551
• 18 Du X, Bai Y, Liang H, Wang Z, Zhao Y, Zhang Q, Huang L. Solvent effect in ¹H NMR spectra of 3′-hydroxy-4′-methoxy isoflavonoids from Astragalus membranaceus var. mongholicus.  Magn Reson Chem. 2006;  44 708-712
• 19 Yin D, Yao W, Chen S, Hu R, Gao X. Salidroside, the main active compound of Rhodiola plants, inhibits high glucose-induced mesangial cell proliferation.  Planta Med. 2009;  75 1191-1195